Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Biocytogen Signs RenMab™/RenLite™ Licensing Agreement with BeiGene 2022-04-08 21:00
Novavax and Serum Institute of India Receive Emergency Use Authorization for Novavax' COVID-19 Vaccine in Thailand 2022-04-08 21:00
OliX Pharmaceuticals Identifies Inhibition of Target Gene Expression in Nonhuman Primate Models for NASH Candidate 2022-04-08 20:00
AGC to Expand Synthetic Pharmaceutical Production Base in Spain 2022-04-08 14:00
CARsgen Appoints Dr. Raffaele Baffa as Chief Medical Officer 2022-04-07 23:42
Henlius' Serplulimab Granted Orphan-Drug Designation in the United States for Small Cell Lung Cancer 2022-04-07 22:21
SIMCERE PHARMA (HK.2096) to host 2022 R&D Day 2022-04-07 21:39
REDCLOUD BIO TO PRESENT PRECLINICAL DATA OF NEXT-GENERATION EGFR TKI H002 AT ANNUAL MEETING OF AMERICAN ASSOCIATION OF CANCER RESEARCH 2022-04-07 19:47
Contract Development and Manufacturing Organizations Shifting Focus to Meet Future Demand 2022-04-07 18:01
Asset Visibility Market Opportunity in the Pharmaceutical Industry Worth US$2.7 Billion by 2026 2022-04-07 16:00
Rona Therapeutics Announces Completion of $33 Million Series A Financing to Advance Global Discovery and Development of RNA Therapeutics 2022-04-07 12:30
Psychobiotic PS128 Registration, Health Claims Approved in Thailand, Canada 2022-04-07 11:20
Alterity Therapeutics Announces Presentation of bioMUSE Data at the American Academy of Neurology (AAN) Annual Meeting 2022-04-07 09:34
Everest Medicines Enters into an MOU for Partnership with China Resources Pharmaceutical Group for its mRNA Vaccine Business 2022-04-07 07:30
ENSEM Therapeutics, a CBC Group-Incubated Biopharma Company, Raises $67 Million in Series A Financing to Develop Small Molecule Medicines for Difficult-to-Drug Targets 2022-04-07 04:00
HitGen and UPPTHERA Extend PROTAC Research Collaboration after Hit Finding Success on Undruggable Targets 2022-04-06 22:30
Seegene's Allplex™ RV Master Assay receives Australian TGA approval, European CE-IVD mark 2022-04-06 20:08
Volition appoints Sharon Ballesteros as U.S. Head of Quality and Development Process 2022-04-06 20:00
Ascletis Announces China IND Approval of Its Second FASN Inhibitor ASC60 for Treatment of Advanced Solid Tumors 2022-04-06 17:10
PSMA-PET Imaging to be Funded through Medicare in Australia from July 2022 2022-04-06 12:47
1 191 192 193 194 195 423